메뉴 건너뛰기




Volumn 16, Issue 9, 2001, Pages 955-957

Hepatitis B surface antigen-positive organ transplantation recipients: Can lamivudine alter their fate?

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; STEROID; VIRUS DNA;

EID: 0034796515     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02578.x     Document Type: Editorial
Times cited : (2)

References (23)
  • 2
    • 2942559300 scopus 로고    scopus 로고
    • A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B
    • (2001) Hepatology , vol.33 , pp. 424-432
    • Perillo, R.P.1    Wright, T.2    Rakela, J.3
  • 8
    • 0029115052 scopus 로고
    • Prevalence and clinical course of hepatitis B and hepatitis C liver disease in cyclosporin-treated renal allograft recipients
    • (1995) Nephron , vol.70 , pp. 397-401
    • Bang, B.K.1    Yang, C.W.2    Yoon, S.A.3
  • 22
    • 0033611144 scopus 로고    scopus 로고
    • Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: Durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin
    • (1999) Transplantation , vol.68 , pp. 1912-1914
    • Peters, M.G.1    Singer, G.2    Howard, T.3
  • 23
    • 0035865376 scopus 로고    scopus 로고
    • Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after dysfunction with HBV recurrence
    • (2001) Transplantation , vol.71 , pp. 387-394
    • Han, D.J.1    Kim, T.H.2    Park, S.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.